EMA Confirms Recommendation Of Synchron Suspensions

But Finds Alternative Data To Support Marketing Authorizations For Eight Medicines

EMA
The EMA has confirmed its recommendation to suspend dozens of marketing authorizations

More from Regulation

More from Policy & Regulation